GeneThera Inc (GTHR)
0.00
USD |
OTCM |
May 17, 16:00
GeneThera 1 Year Total Returns (Daily)
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
February 16, 2024 | -60.00% |
February 15, 2024 | -60.00% |
February 14, 2024 | -60.26% |
February 13, 2024 | -60.26% |
February 12, 2024 | -60.26% |
February 09, 2024 | -60.26% |
February 08, 2024 | -60.26% |
February 07, 2024 | -60.26% |
February 06, 2024 | -60.26% |
February 05, 2024 | -60.26% |
February 02, 2024 | -60.26% |
February 01, 2024 | -60.26% |
January 31, 2024 | -60.26% |
January 30, 2024 | -60.26% |
January 29, 2024 | -60.26% |
January 26, 2024 | -60.26% |
January 25, 2024 | -60.26% |
January 24, 2024 | -60.26% |
January 23, 2024 | -60.26% |
January 22, 2024 | -60.00% |
January 19, 2024 | -60.00% |
January 18, 2024 | -60.00% |
January 17, 2024 | -60.00% |
January 16, 2024 | -60.00% |
January 12, 2024 | -60.00% |
Date | Value |
---|---|
January 11, 2024 | -60.00% |
January 10, 2024 | -60.00% |
January 09, 2024 | -53.85% |
January 08, 2024 | -53.85% |
January 05, 2024 | -1.64% |
January 04, 2024 | -1.64% |
January 03, 2024 | -1.64% |
January 02, 2024 | -1.64% |
December 29, 2023 | -64.91% |
December 28, 2023 | -64.91% |
December 27, 2023 | -64.91% |
December 26, 2023 | -64.91% |
December 22, 2023 | -64.91% |
December 21, 2023 | -64.91% |
December 20, 2023 | -64.71% |
December 19, 2023 | -64.71% |
December 18, 2023 | -64.71% |
December 15, 2023 | -64.71% |
December 14, 2023 | -64.71% |
December 13, 2023 | -64.71% |
December 12, 2023 | -64.71% |
December 11, 2023 | -64.71% |
December 08, 2023 | -45.45% |
December 07, 2023 | -45.45% |
December 06, 2023 | -45.45% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-87.65%
Minimum
Aug 23 2019
2.86K%
Maximum
Jul 10 2020
126.0%
Average
-26.66%
Median
Jul 01 2022
1 Year Total Returns (Daily) Benchmarks
AIM ImmunoTech Inc | -19.40% |
Perspective Therapeutics Inc | 252.7% |
Protalix BioTherapeutics Inc | -51.69% |
Electromed Inc | 32.31% |
Armata Pharmaceuticals Inc | 107.2% |